Literature DB >> 26169984

Novel protein-protein interactions of TPPII, p53, and SIRT7.

Jarmila Nahálková1.   

Abstract

Novel protein-protein interactions of TPPII, SIRT7, and p53 were detected by co-immunoprecipitation using both HeLa cell lysates and the cytoplasmic fraction prepared by fractionation of mouse liver tissue. The interactions were further verified in vivo by in situ proximity ligation assay (PLA) within control HEK293 cells transformed with empty vector, highactTPPII HEK293 cells over-expressing murine TPPII displaying high specific enzymatic activity and in lowactTPPII HEK293 cells over-expressing human TPPII having low specific activity of the enzyme. Besides an abundant cytoplasmic localization of TPPII-p53 interaction signal, the nuclear interactions were also demonstrated. The cytoplasmic interactions were likewise detected between TPPII and SIRT7 in control HEK293 and lowactTPPII HEK293 cells. The interactions of SIRT7 with p53 were confirmed in three HEK293 cell transformants as well. The cytoplasmic occurrence of SIRT7 protein was demonstrated by immunofluorescence, when both nucleolar and cytoplasmic signals were identified within HEK293 cells and primary human fibroblasts. The unique cytoplasmic localization of SIRT7 protein was discussed based on an epitope specificity of N-terminus specific SIRT7 antibodies utilized in the present study compared with C-terminus specific antibodies previously used for nuclear detection of SIRT7 by other authors. The epitope sequence of N-terminal antibodies is occurring in all three splicing variants of SIRT7 compared to the epitope of C-terminal antibody, which is specific exclusively to the splicing variant 1. The cytoplasmic localization of p53 detected by immunofluorescence supported the results from its interactions with TPPII and SIRT7 observed by in situ PLA within model cells. Novel interactions of TPPII, p53, and SIRT7 presented in this study might contribute to the knowledge of the regulatory effects of these proteins on apoptotic pathways and to the understanding mechanisms of aging and lifespan regulation.

Entities:  

Keywords:  Aging; Apoptosis; Cellular senescence; SIRT7; TPPII; p53

Mesh:

Substances:

Year:  2015        PMID: 26169984     DOI: 10.1007/s11010-015-2507-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  35 in total

1.  c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells.

Authors:  R Gavioli; T Frisan; S Vertuani; G W Bornkamm; M G Masucci
Journal:  Nat Cell Biol       Date:  2001-03       Impact factor: 28.824

2.  A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation.

Authors:  Eric Reits; Joost Neijssen; Carla Herberts; Willemien Benckhuijsen; Lennert Janssen; Jan Wouter Drijfhout; Jacques Neefjes
Journal:  Immunity       Date:  2004-04       Impact factor: 31.745

3.  p53 is localized to a sub-nucleolar compartment after proteasomal inhibition in an energy-dependent manner.

Authors:  Orit Karni-Schmidt; Andrew Zupnick; Mirela Castillo; Aqeel Ahmed; Tulio Matos; Philippe Bouvet; Carlos Cordon-Cardo; Carol Prives
Journal:  J Cell Sci       Date:  2008-11-25       Impact factor: 5.285

4.  MYBBP1a is a novel repressor of NF-kappaB.

Authors:  Heather R Owen; Michael Elser; Edwin Cheung; Monika Gersbach; W Lee Kraus; Michael O Hottiger
Journal:  J Mol Biol       Date:  2006-12-15       Impact factor: 5.469

5.  Characterization and inhibition of a cholecystokinin-inactivating serine peptidase.

Authors:  C Rose; F Vargas; P Facchinetti; P Bourgeat; R B Bambal; P B Bishop; S M Chan; A N Moore; C R Ganellin; J C Schwartz
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

Review 6.  After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders.

Authors:  Kilian Huber; Giulio Superti-Furga
Journal:  Bioorg Med Chem       Date:  2011-01-15       Impact factor: 3.641

7.  Direct observation of individual endogenous protein complexes in situ by proximity ligation.

Authors:  Ola Söderberg; Mats Gullberg; Malin Jarvius; Karin Ridderstråle; Karl-Johan Leuchowius; Jonas Jarvius; Kenneth Wester; Per Hydbring; Fuad Bahram; Lars-Gunnar Larsson; Ulf Landegren
Journal:  Nat Methods       Date:  2006-10-29       Impact factor: 28.547

8.  Jalview Version 2--a multiple sequence alignment editor and analysis workbench.

Authors:  Andrew M Waterhouse; James B Procter; David M A Martin; Michèle Clamp; Geoffrey J Barton
Journal:  Bioinformatics       Date:  2009-01-16       Impact factor: 6.937

9.  A role for both RB and p53 in the regulation of human cellular senescence.

Authors:  J W Shay; O M Pereira-Smith; W E Wright
Journal:  Exp Cell Res       Date:  1991-09       Impact factor: 3.905

Review 10.  The P53 pathway: what questions remain to be explored?

Authors:  A J Levine; W Hu; Z Feng
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

View more
  9 in total

Review 1.  The protein-interaction network with functional roles in tumorigenesis, neurodegeneration, and aging.

Authors:  Jarmila Nahálková
Journal:  Mol Cell Biochem       Date:  2016-10-03       Impact factor: 3.396

2.  Oligomerization of MrgC11 and μ-opioid receptors in sensory neurons enhances morphine analgesia.

Authors:  Shao-Qiu He; Qian Xu; Vinod Tiwari; Fei Yang; Michael Anderson; Zhiyong Chen; Shaness A Grenald; Srinivasa N Raja; Xinzhong Dong; Yun Guan
Journal:  Sci Signal       Date:  2018-06-19       Impact factor: 8.192

3.  USP17L2-SIRT7 axis regulates DNA damage repair and chemoresistance in breast cancer cells.

Authors:  Yang Su; Chenming Wu; Yiming Chang; Lei Li; Yuping Chen; Xuebing Jia; Xinshu Wang; Ying Lv; Bentong Yu; Jian Yuan
Journal:  Breast Cancer Res Treat       Date:  2022-08-30       Impact factor: 4.624

4.  Sirtuin 7-mediated deacetylation of WD repeat domain 77 (WDR77) suppresses cancer cell growth by reducing WDR77/PRMT5 transmethylase complex activity.

Authors:  Hao Qi; Xiaoyan Shi; Miao Yu; Boya Liu; Minghui Liu; Shi Song; Shuaiyi Chen; Junhua Zou; Wei-Guo Zhu; Jianyuan Luo
Journal:  J Biol Chem       Date:  2018-10-03       Impact factor: 5.157

Review 5.  Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes.

Authors:  Nady Braidy; Jade Berg; James Clement; Fatemeh Khorshidi; Anne Poljak; Tharusha Jayasena; Ross Grant; Perminder Sachdev
Journal:  Antioxid Redox Signal       Date:  2018-05-11       Impact factor: 8.401

Review 6.  Advances in Cellular Characterization of the Sirtuin Isoform, SIRT7.

Authors:  Di Wu; Yinglu Li; Kathy S Zhu; Haiying Wang; Wei-Guo Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-19       Impact factor: 5.555

7.  Influence of psychostimulants and opioids on epigenetic modification of class III histone deacetylase (HDAC)-sirtuins in glial cells.

Authors:  Kalaiselvi Sivalingam; Mayur Doke; Mansoor A Khan; Thangavel Samikkannu
Journal:  Sci Rep       Date:  2021-10-29       Impact factor: 4.379

8.  Interleukin-1α associates with the tumor suppressor p53 following DNA damage.

Authors:  J Novak; B Zamostna; V Vopalensky; M Buryskova; L Burysek; D Doleckova; M Pospisek
Journal:  Sci Rep       Date:  2020-04-24       Impact factor: 4.379

Review 9.  The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy.

Authors:  Guo Li; Yuan Tian; Wei-Guo Zhu
Journal:  Front Cell Dev Biol       Date:  2020-09-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.